Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SciGenom Labs is an India-based private genomics and bioinformatics company that provides genome sequencing, bioinformatics analysis, molecular testing, and related R&D services for life science, healthcare, agriculture, and drug discovery applications. The company was founded by Sam Santhosh and built early sequencing and computational biology capabilities in India, positioning itself as both a service provider and a genomics incubator. SciGenom has also helped incubate and spin out other companies, including MedGenome, AgriGenome, Saksin Life Sciences, and MagGenome. Its capabilities span next-generation sequencing, Sanger sequencing, custom oligonucleotide synthesis, cloning, microbial identification, and development of multigene oncology diagnostics. Overall, SciGenom appears to be a commercial-stage genomics infrastructure and services business rather than a therapeutics developer with a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SciGenom Labs.